Bruker Announces new Mass Spectrometry Joint Venture in India
News Aug 03, 2009
Bruker Daltonics has announced the establishment of the Bruker LabMate Private Limited company, a life-science mass spectrometry joint venture between Bruker Daltonics and LabMate Asia, with customer support and technical expertise hubs in Bangalore, Chennai, Delhi, Kolkata and Mumbai.
Building on a successful partnership built over 7 years with Bruker's Indian mass spectrometry distributor LabMate Asia Pvt., the new company marks a seamless transition of established business and customer care teams to a majority-owned Bruker company.
At the core of the establishment of this Bruker LabMate joint venture is a firm commitment to customer service, training and support made fully accessible to Bruker Daltonics' top-tier academic and pharmaceutical industry clients by a geographically distributed technical staffing structure.
"We already set the customer care standards in India by which other research mass spectrometry suppliers are judged, and we see it as directly responsible for our success," commented Dr. Ian Sanders, Executive Vice President of Bruker Daltonics. He continued: "Adding to our training and applications strength in India is the logical next move to ensure our customers succeed as quickly as possible in this very exciting and dynamic scientific community."
"We are excited to enter this next phase of growth for our achievements as mass spectrometry pioneers in India," commented Mr. S. Viswanathan, an Executive Director of Bruker LabMate, who together with Executive Director Mr. S. Kumaraguruparan, bring over 40 years of combined experience in scientific instrumentation supply to the management of Bruker LabMate.
Speaking at the inauguration of the Bruker Indian Institute of Science Mass Spectrometry Facility in Bangalore on 23rd July 2009, Mr. Kumar concluded: "This is great news for our customers, adding the full commitment of Bruker Daltonics behind our very long-standing and close relationships with many key Indian scientists."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019